Is there glycemic threshold for mortality risk?

被引:125
作者
Balkau, B [1 ]
Bertrais, S [1 ]
Ducimetiere, P [1 ]
Eschwege, E [1 ]
机构
[1] INSERM, U258, F-94807 Villejuif, France
关键词
D O I
10.2337/diacare.22.5.696
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - To determine whether there are thresholds for fasting and for 2-h glucose above which the risk of death from all causes and from coronary heart disease (CHD) increases. RESEARCH DESIGN AND METHODS - We studied 23-year mortality data from the Paris Prospective Study of the 7,018 men, aged 44-55 years, who were not known as diabetic at the baseline examination. The effect of glucose concentrations on mortality was studied using the observed relative risks and an age-adjusted Cox proportional hazards model. RESULTS - For all causes of death, there were J-shaped relationships with both fasting and 2-h glucose concentrations, and the lowest observed death rates were in the intervals centered on 5.5 mmol/l for fasting glucose and 5.0 mmol/l for 2-h glucose. The death rates for CHD were low in this population: for fasting glucose, the hazards ratio was best modeled by a positive linear relationship; for 2-h glucose, it was modeled by a J-shaped curve and the lowest observed death rate was in the interval centered on 6.0 mmol/l. CONCLUSIONS - In the Paris Prospective Study, there were no clear thresholds for fasting or 2-h glucose concentrations above which mortality sharply increased; in the upper levels of the glucose distributions, the risk of death progressively increased with increasing fasting and 2-h glucose concentrations.
引用
收藏
页码:696 / 699
页数:4
相关论文
共 12 条
[1]
[Anonymous], 1975, International Classification of Diseases
[2]
RISK-FACTORS FOR EARLY DEATH IN NON-INSULIN-DEPENDENT DIABETES AND MEN WITH KNOWN GLUCOSE-TOLERANCE STATUS [J].
BALKAU, B ;
ESCHWEGE, E ;
PAPOZ, L ;
RICHARD, JL ;
CLAUDE, JR ;
WARNET, JM ;
DUCIMETIERE, P .
BRITISH MEDICAL JOURNAL, 1993, 307 (6899) :295-299
[3]
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[4]
Balkau B, 1997, DIABETES METAB, V23, P428
[5]
CARDIOVASCULAR AND ALCOHOL-RELATED DEATHS IN ABNORMAL GLUCOSE TOLERANT AND DIABETIC SUBJECTS [J].
BALKAU, B ;
ESCHWEGE, E ;
FONTBONNE, A ;
CLAUDE, JR ;
WARNET, JM .
DIABETOLOGIA, 1992, 35 (01) :39-44
[6]
Cryer PE, 1992, WILLIAMS TXB ENDOCRI, P1223
[7]
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]
Is there a glycemic threshold for mortality risk? [J].
Harris, MI ;
Eastman, RC .
DIABETES CARE, 1998, 21 (03) :331-333
[9]
COMPARISON OF TESTS FOR GLYCATED HEMOGLOBIN AND FASTING AND 2 HOUR PLASMA-GLUCOSE CONCENTRATIONS AS DIAGNOSTIC METHODS FOR DIABETES [J].
MCCANCE, DR ;
HANSON, RL ;
CHARLES, MA ;
JACOBSSON, LTH ;
PETTITT, DJ ;
BENNETT, PH ;
KNOWLER, WC .
BRITISH MEDICAL JOURNAL, 1994, 308 (6940) :1323-1328
[10]
Report of a WHO Study Group, 1985, WHO TECH REP SER